World Disposable Medical Supplies to 2016

World demand to rise 6.4% annually through 2016


Dallas, TX -- (ReleaseWire) -- 10/30/2012 -- Global demand for disposable medical supplies is projected to grow 6.4 percent annually to nearly $200 billion in 2016. The upgrading and enforcement of infection prevention standards, coupled with an expanding volume of hospital, surgical and outpatient procedures, will promote overall gains. The United States, China, Japan, Germany, Russia, France, India, Italy, the United Kingdom, and Brazil will comprise the ten largest geographical markets, combining to absorb nearly 70 percent of global demand in 2016. During the forecast period (2011-2016), average annual growth in these markets will range from 3.7 percent in Japan to nearly 13 percent in China.

Demand for disposable medical supplies in the United States, Western Europe, Japan and virtually all other developed countries will expand at a below average pace through 2016 and beyond, given that medical delivery systems are well established, meet the health care needs of most residents, and have already adopted stringent infection prevention standards. By contrast, growth in China, India, Brazil, Russia, and many other emerging economies will exceed the world average as health care sectors are expanded, modernized, and adapted to formal infection prevention protocols.

Dialysis disposables to be fastest growing products

The range of disposable medical supplies consumed worldwide extends into 11 major product segments and 8 additional product lines. Among the major product segments, world demand in 2016 will range from $7.5 billion for patient room supplies to $32.2 billion for surgical instruments and supplies. Dialysis disposables will realize the fastest growth based on an increasing global prevalence of serious renal disorders. Other product segments projected to see above average gains in demand include infusion and hypodermic devices, diagnostic and laboratory disposables, nonwoven garments and textiles, and respiratory supplies and devices. The fastest growth among the eight additional product lines will evolve in transdermal patches, urinary catheters and accessories, and first aid kits.

Advances in disposable medical supplies are contributing significant improvements to the safety and outcome of patient procedures. Products such as Level 4 microbial resistant surgical gowns and drapes have greatly reduced the risk of spreading air- and blood-borne infections during surgery. New polymer and bioengineered tissue sealants are decreasing the length of many surgical procedures and are promoting the faster recovery of post-operative patients.

Disposable drug delivery supplies also to grow rapidly

Drug delivery comprises another fast growing application served by disposable medical supplies. New and improved safety-engineered prefillable and hypodermic syringes and IV catheters have substantially lowered the risk of accidental staff and patient needlesticks before and after medication injections. Innovations in prefilled inhalers and transdermal patches are expanding the range of chronic conditions adaptable to cost effective self treatment. In addition to drug delivery, innovations in disposable medical supplies are enabling patients to self perform a number of other health care functions, including blood glucose testing, urinary drainage, and chronic wound management.

Buy your copy of this report @ http://www.rnrmarketresearch.com/world-disposable-medical-supplies-to-2016-market-report.html .

Company Profiles for 36 global competitors including B. Braun Melsungen, Covidien, Johnson & Johnson, Kimberly-Clark, 3M and more.

Major Company Profiles
1. Abbott Laboratories
2. Acclarent, see Johnson & Johnson
3. Advanced Medical Solutions Group plc
4. Ahlstrom Corporation
5. Ansell Limited
6. Ardian, see Medtronic
7. Aso LLC
8. Attends Healthcare Products, see Domtar
9. Bard (CR) Incorporated
10. Baxa, see Baxter International
11. Baxter International Incorporated
12. Bayer AG
13. Becton, Dickinson and Company
14. Biosense Webster, see Johnson & Johnson
15. Boston Scientific Corporation
16. Braun (B.) Melsungen AG
17. BSN medical GmbH
18. Cardinal Health Incorporated
19. CaridianBCT Holding, see Terumo
20. Cederroth Intressenter AB
21. Codman & Shurtleff, see Johnson & Johnson
22. Coloplast A/S
23. Conor Medsystems, see Johnson & Johnson
24. ConvaTec Incorporated
25. Cordis, see Johnson & Johnson
26. Covidien plc
27. Degasa SA de CV
28. DePuy, see Johnson & Johnson
29. Derma Sciences Incorporated
30. Domtar Corporation
31. Ethicon, see Johnson & Johnson
32. ev3, see Covidien
33. Guangzhou Bioseal Biotech, see Johnson & Johnson
34. Hartmann (Paul) AG
35. Hospira Incorporated
36. I-Flow, see Kimberly-Clark
37. International Surgical Products, see Medline Industries
38. Janssen Pharmaceuticals, see Johnson & Johnson
39. Johnson & Johnson
40. Karl Otto Braun, see Hartmann (Paul)
41. Kimberly-Clark Corporation
42. LifeScan, see Johnson & Johnson
43. Lohmann & Rauscher GmbH & Company KG
44. Lutonix, see Bard (CR)
45. MedEfficiency, see Derma Sciences
46. Medline Industries Incorporated
47. Medtronic Incorporated
48. Mölnlycke Health Care AB
49. Onset Medical, see Terumo
50. Pro Descart Industria e Comercio Limitada,see Svenska Cellulosa
51. RESORBA Wundversorgung, see Advanced Medical Solutions Group
52. Roche Holding Limited 512
53. San Saglik Urunleri, see Svenska Cellulosa
54. Sandel Medical Industries, see Ansell
55. SCHOTT AG 514
56. Semperit AG Holding 516
57. Siam Sempermed, see Semperit Holding
58. Smith & Nephew plc 520
59. Smiths Group plc 524
60. Svenska Cellulosa AB 528
61. Systagenix Wound Management Limited 531
62. Teleflex Incorporated 533
63. Terumo Corporation 540
64. 3M Company 544
65. Unomedical A/S, see ConvaTec
66. Additional Companies Mentioned in the Study 549

Contact sales@rnrmarketresearch.com for further information.